PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-10

Date Title Company
10-Oct-2025 Medincell: FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder Businesswire
10-Oct-2025 Medincell : La FDA approuve l’extension d’indication de UZEDY® pour le traitement de patients atteints de trouble bipolaire de type I Businesswire
10-Oct-2025 Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
10-Oct-2025 Rosen Law Firm Urges aTyr Pharma, Inc. (NASDAQ: ATYR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights Businesswire
10-Oct-2025 Axway Named a Leader in the 2025 Gartner® Magic Quadrant™ for API Management for the 10th Time Businesswire
10-Oct-2025 IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders ACCESS Newswire
10-Oct-2025 Mundipharma meldet Abschluss der Patientenanmeldung für die klinische Phase-III-Studie ReSPECT zu REZZAYO® (Rezafungin) Businesswire
10-Oct-2025 Mundipharma anuncia finalização das inscrições de pacientes no ensaio clínico ReSPECT de Fase III sobre o REZZAYO® (rezafungina) Businesswire
10-Oct-2025 Number of Shares and Voting Rights of ADOCIA as of September 30th, 2025 Businesswire
10-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-Oct-2025 ProSpecBio Launches Activin-A Recombinant Protein, Empowering Global Research in Inflammation and Brain Injury Businesswire
10-Oct-2025 Mundipharma宣布,REZZAYO®(雷扎芬淨)III期ReSPECT臨床試驗已完成病患招募 Businesswire
10-Oct-2025 Mundipharma宣布,REZZAYO®(雷扎芬净)III期ReSPECT临床试验已完成患者招募 Businesswire
10-Oct-2025 Global Quantum Technology Market Report 2026-2046, with Detailed Company Profiling of 330+ Leading Quantum Technology Organizations Worldwide - ResearchAndMarkets.com Businesswire
10-Oct-2025 JEF BREAKING NEWS: BFA Law is Investigating Jefferies Financial Group Inc. and Point Bonita Capital for Securities Violations after Significant Exposure to First Brands’ Bankruptcy -- Investors Urged to Contact the Firm Businesswire
10-Oct-2025 Satellos Announces New Data Further Demonstrating Safety, Tolerability, and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy Businesswire
10-Oct-2025 Saudi Arabia Essential Oils Market Report 2025: Rising Consumer Preference for Natural Products Drives Market to Reach $198.24 Million by 2030 - ResearchAndMarkets.com Businesswire
10-Oct-2025 Mundipharma anuncia la finalización de la inscripción de pacientes para el ensayo clínico de fase III ReSPECT con REZZAYO® (rezafungina) Businesswire
10-Oct-2025 Mundipharma annonce la fin du recrutement des patients dans l'essai clinique de phase III ReSPECT pour REZZAYO® (rézafungine) Businesswire
10-Oct-2025 ME Therapeutics Added to CSE25 Index Businesswire